| Primary |
| Meningitis |
17.2% |
| Drug Use For Unknown Indication |
14.9% |
| Infection |
14.0% |
| Sepsis |
7.2% |
| Prophylaxis |
6.3% |
| Bronchitis |
5.9% |
| Antibiotic Therapy |
4.5% |
| Pneumonia |
4.5% |
| Pain |
4.1% |
| Asthma |
3.6% |
| Bacterial Sepsis |
2.7% |
| Sepsis Neonatal |
2.7% |
| Lung Disorder |
1.8% |
| Meningoencephalitis Bacterial |
1.8% |
| Sepsis Nos |
1.8% |
| Abscess |
1.4% |
| Brain Abscess |
1.4% |
| Cough |
1.4% |
| Leptospirosis |
1.4% |
| Lower Respiratory Tract Infection |
1.4% |
|
| Renal Failure Acute |
14.0% |
| Thrombocytopenia |
14.0% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
7.0% |
| Meningitis |
7.0% |
| Toxic Epidermal Necrolysis |
7.0% |
| Pancytopenia |
5.8% |
| Pyrexia |
5.8% |
| Acute Generalised Exanthematous Pustulosis |
4.7% |
| Lymphadenopathy |
3.5% |
| Pancreatitis Acute |
3.5% |
| Stevens-johnson Syndrome |
3.5% |
| Urticaria |
3.5% |
| Visual Acuity Reduced |
3.5% |
| Vomiting |
3.5% |
| Bone Marrow Failure |
2.3% |
| Deafness |
2.3% |
| Death |
2.3% |
| Drug Exposure During Pregnancy |
2.3% |
| Hepatic Failure |
2.3% |
| Hepatocellular Damage |
2.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
16.7% |
| Meningitis |
16.3% |
| Product Used For Unknown Indication |
11.8% |
| Lung Disorder |
7.3% |
| Infection |
6.2% |
| Sepsis |
6.0% |
| Pneumonia Necrotising |
5.6% |
| Pyrexia |
3.6% |
| Antibiotic Therapy |
3.2% |
| Endocarditis |
2.9% |
| Bacterial Infection |
2.8% |
| Hypertension |
2.4% |
| Pneumonia |
2.4% |
| Septic Shock |
2.4% |
| Pneumonia Pneumococcal |
2.1% |
| Brain Abscess |
2.0% |
| Meningitis Bacterial |
1.7% |
| Asthma |
1.6% |
| Escherichia Infection |
1.6% |
| Oedema |
1.6% |
|
| Thrombocytopenia |
15.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
12.7% |
| Agranulocytosis |
6.7% |
| Pyrexia |
6.1% |
| Meningitis |
5.5% |
| Pancreatitis |
5.5% |
| Renal Failure Acute |
4.8% |
| Toxic Epidermal Necrolysis |
4.8% |
| Septic Shock |
4.2% |
| Toxic Skin Eruption |
4.2% |
| Cytolytic Hepatitis |
3.6% |
| Drug Exposure During Pregnancy |
3.6% |
| Surgery |
3.6% |
| Weight Decreased |
3.6% |
| Eosinophilia |
3.0% |
| Hepatocellular Injury |
2.4% |
| Hyponatraemia |
2.4% |
| Neutropenia |
2.4% |
| Rash Generalised |
2.4% |
| Sepsis |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
14.9% |
| Product Used For Unknown Indication |
14.6% |
| Asthma |
8.9% |
| Hypertension |
7.1% |
| Pain |
6.7% |
| Pneumonia |
6.6% |
| Prophylaxis |
5.8% |
| Bronchitis |
4.1% |
| Meningitis |
4.0% |
| Antibiotic Therapy |
3.6% |
| Sedation |
3.3% |
| Otitis Media |
2.8% |
| Sepsis |
2.8% |
| Pyrexia |
2.6% |
| Renal Transplant |
2.3% |
| Upper Respiratory Tract Inflammation |
2.3% |
| Acute Lymphocytic Leukaemia |
2.0% |
| Diarrhoea |
1.9% |
| Infection |
1.9% |
| Renal Cell Carcinoma |
1.9% |
|
| Renal Failure Acute |
11.8% |
| Thrombocytopenia |
11.8% |
| Septic Shock |
6.6% |
| Pneumonia |
5.9% |
| Portal Vein Thrombosis |
5.1% |
| Weight Increased |
5.1% |
| Wrong Technique In Drug Usage Process |
5.1% |
| Renal Failure |
4.4% |
| Seroma |
4.4% |
| Toxic Skin Eruption |
4.4% |
| Vasculitis |
4.4% |
| Hepatic Enzyme Increased |
3.7% |
| Nephrogenic Diabetes Insipidus |
3.7% |
| Respiratory Failure |
3.7% |
| Toxic Epidermal Necrolysis |
3.7% |
| Vomiting |
3.7% |
| Weight Decreased |
3.7% |
| Bone Marrow Failure |
2.9% |
| Cytolytic Hepatitis |
2.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.9% |
|
| Interacting |
| Infection |
66.7% |
| Atrial Fibrillation |
33.3% |
|
| International Normalised Ratio Increased |
100.0% |
|
